5 However, concerns have been raised about the potential for muscle loss due to long-term Semaglutide use
The difference is risk profile: oral bioavailability of glutathione is low (most is broken down in the GI tract), so safety concerns are minimal
What You Should Know About NAION Lawsuits Related to GLP-1 Use People taking glucagon-like peptide-1 (GLP-1) medications for diabetes or weight loss have experienced a significantly higher rate of the development of non-arteric ischemic optic neuropathy (NAION)
To qualify for the bridge, patients must be using their GLP-1 for weight management, along with lifestyle modifications like diet, exercise, that kind of thing
Dosing: 40-80mcg per day, for 4-6 week cycles Requires cycling (not continuous use) Timeline: Hair improvements visible around 6-8 weeks into cycle
Its efficacy and safety profile are well-documented, providing confidence to patients and healthcare providers